Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-808-8
CAS number: 88-19-7
Table 1. Elimination of 14C by rat and given [14C]toluene-2-sulphonamide
% of dose of 14C in (CL)
92 ( 83-1 02)
A study on the metabolism and excretion of the test item (14C-labelled)
was performed in female Wistar rats. A single dose of 20, 125 or 200
mg/kg radiolabelled test item was administered via oral gavage to 3
females each and the concentrations of the test item in urine and faeces
were determined daily by TLC and GC-MS. The metabolites were identified
and quantified. A study in humans (2M, 1F) was conducted in parallel to
observe similarities. The 20 mg/kg doses were rapidly eliminated by rats
(92% in 24 h), mostly in urine (88%), with little (5%) in the faeces.
Larger oral doses were eliminated more slowly but the overall
distribution of 14C between urine and faeces was unchanged. The main
metabolite of [Me-14C] toluene-2-sulphonamide in rat and man is
2-sulphamoylbenzyl alcohol with smaller amounts of saccharin,
2-sulphamoylbenzoic acid, N-acetyltoluene-2-sulphonamide, and with
little excreted as unchanged compound.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
På den här webbplatsen används kakor. Syftet är att optimera din upplevelse av den.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again